A Study of LY3337641 in Japanese and Caucasian Healthy Participants

NCT03083561 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3337641
DRUG: Placebo

Sponsor

Eli Lilly and Company